1-anilino-8-naphthalenesulfonate has been researched along with Metabolic Diseases in 24 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both individuals with type 1 diabetes mellitus (mean difference = -1." | 2.66 | Low serum amylase, lipase, and trypsin as biomarkers of metabolic disorders: A systematic review and meta-analysis. ( Cho, J; Ko, J; Petrov, MS, 2020) |
| "Obesity is the main feature of a complex illness known as metabolic syndrome." | 1.51 | Leopoldia comosa prevents metabolic disorders in rats with high-fat diet-induced obesity. ( Amelio, D; Angelone, T; Beretta, G; Casacchia, T; Gelmini, F; Granieri, MC; Mazza, R; Pasqua, T; Rocca, C; Scavello, F; Spena, A; Statti, G; Toma, CC, 2019) |
| "To find association of pediatric NAFLD with metabolic risk factors, and Patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene polymorphism." | 1.48 | Study of Family Clustering and PNPLA3 Gene Polymorphism in Pediatric Non Alcoholic Fatty Liver Disease. ( Alam, S; Khanna, R; Rawat, D; Sarin, SK; Sharma, S; Sood, V, 2018) |
| " These negative associations between clinical risk factors and rs738409-G dosage were more prominent in non-NAFLD group compared to those in NAFLD group." | 1.42 | I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease. ( Cho, B; Choi, HC; Hwang, KB; Kim, JI; Kong, SW; Kwon, H; Lee, IH; Park, JH; Prilutsky, D; Yun, JM, 2015) |
| " The latter may generally be reduced by progressive and individual titration of the dosage of each drug and/or by following an appropriate diet." | 1.30 | [Drug clinics. How I treat various metabolic diseases treated by a drug intervention that targets the intestine]. ( Scheen, AJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (29.17) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 7 (29.17) | 24.3611 |
| 2020's | 5 (20.83) | 2.80 |
| Authors | Studies |
|---|---|
| Tung, YT | 1 |
| Wu, CH | 1 |
| Chen, WC | 1 |
| Pan, CH | 1 |
| Chen, YW | 2 |
| Tsao, SP | 1 |
| Chen, CJ | 1 |
| Huang, HY | 1 |
| Tenuta, MC | 1 |
| Loizzo, MR | 1 |
| Tundis, R | 1 |
| Dugay, A | 1 |
| Bouzidi, C | 1 |
| Marie, A | 1 |
| Acquaviva, R | 1 |
| Cappello, AR | 1 |
| Deguin, B | 1 |
| Ko, J | 1 |
| Cho, J | 1 |
| Petrov, MS | 1 |
| Gottesman-Katz, L | 1 |
| Chung, W | 1 |
| Hernan, R | 1 |
| DeFelice, AR | 1 |
| Chiu, YJ | 1 |
| Tu, HH | 1 |
| Kung, ML | 1 |
| Wu, HJ | 1 |
| Stegmayr, B | 1 |
| Casacchia, T | 1 |
| Scavello, F | 1 |
| Rocca, C | 1 |
| Granieri, MC | 1 |
| Beretta, G | 1 |
| Amelio, D | 1 |
| Gelmini, F | 1 |
| Spena, A | 1 |
| Mazza, R | 1 |
| Toma, CC | 1 |
| Angelone, T | 1 |
| Statti, G | 1 |
| Pasqua, T | 1 |
| Sood, V | 1 |
| Khanna, R | 1 |
| Rawat, D | 1 |
| Sharma, S | 1 |
| Alam, S | 1 |
| Sarin, SK | 1 |
| Nielsen, TS | 1 |
| Jessen, N | 1 |
| Jørgensen, JO | 1 |
| Møller, N | 1 |
| Lund, S | 1 |
| Shimada, T | 1 |
| Nakayama, Y | 1 |
| Harasawa, Y | 1 |
| Matsui, H | 1 |
| Kobayashi, H | 1 |
| Sai, Y | 1 |
| Miyamoto, K | 1 |
| Tomatsu, S | 1 |
| Aburada, M | 1 |
| Park, JH | 1 |
| Cho, B | 1 |
| Kwon, H | 1 |
| Prilutsky, D | 1 |
| Yun, JM | 1 |
| Choi, HC | 1 |
| Hwang, KB | 1 |
| Lee, IH | 1 |
| Kim, JI | 1 |
| Kong, SW | 1 |
| Kimura, H | 1 |
| Usui, F | 1 |
| Karasawa, T | 1 |
| Kawashima, A | 1 |
| Shirasuna, K | 1 |
| Inoue, Y | 1 |
| Komada, T | 1 |
| Kobayashi, M | 1 |
| Mizushina, Y | 1 |
| Kasahara, T | 1 |
| Suzuki, K | 1 |
| Iwasaki, Y | 1 |
| Yada, T | 1 |
| Caturegli, P | 1 |
| Takahashi, M | 1 |
| Rychlik, A | 1 |
| MANETTI, E | 2 |
| SAILER, S | 1 |
| SANDHOFER, F | 1 |
| BRAUNSTEINER, H | 1 |
| Wirth, A | 1 |
| Schettler, G | 1 |
| Baniel, J | 1 |
| Leibovitch, I | 1 |
| Foster, RS | 1 |
| Rowland, RG | 1 |
| Bihrle, R | 1 |
| Donohue, JP | 1 |
| Scheen, AJ | 1 |
| Keating, JP | 1 |
| Lowe, ME | 1 |
| Galton, DJ | 1 |
| Blomhoff, JP | 1 |
| Oleneva, VA | 1 |
| Zikeeva, VK | 1 |
| Gatti, R | 1 |
| Tassara, A | 1 |
| Vignola, G | 1 |
| Harkins, RW | 1 |
| Sarett, HP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Lipolytic Effects of GH in Human Subjects in Vivo: Molecular Mechanisms and Temporal Patterns[NCT02782221] | 9 participants (Actual) | Interventional | 2016-05-30 | Completed | |||
| Lipolytic Effects of GH in Hypopituitary Patients in Vivo: Molecular Mechanisms and Temporal Patterns.[NCT02782208] | 9 participants (Actual) | Interventional | 2016-02-10 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for 1-anilino-8-naphthalenesulfonate and Metabolic Diseases
| Article | Year |
|---|---|
Low serum amylase, lipase, and trypsin as biomarkers of metabolic disorders: A systematic review and meta-analysis.
Topics: Amylases; Biomarkers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Lipase; Metaboli | 2020 |
Dialysis Procedures Alter Metabolic Conditions.
Topics: Amino Acids; Cholesterol; Diet; Dietary Carbohydrates; Dietary Proteins; Fatty Acids, Nonesterified; | 2017 |
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease.
Topics: Adipocytes; Adipose Tissue; Animals; Catecholamines; Energy Metabolism; Fatty Acids, Nonesterified; | 2014 |
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease.
Topics: Adipocytes; Adipose Tissue; Animals; Catecholamines; Energy Metabolism; Fatty Acids, Nonesterified; | 2014 |
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease.
Topics: Adipocytes; Adipose Tissue; Animals; Catecholamines; Energy Metabolism; Fatty Acids, Nonesterified; | 2014 |
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease.
Topics: Adipocytes; Adipose Tissue; Animals; Catecholamines; Energy Metabolism; Fatty Acids, Nonesterified; | 2014 |
Lipoproteins, lipases, and the metabolic cardiovascular syndrome.
Topics: Blood Glucose; Cardiovascular Diseases; Coronary Disease; Down-Regulation; Eating; Fatty Acids, None | 1992 |
1 trial available for 1-anilino-8-naphthalenesulfonate and Metabolic Diseases
| Article | Year |
|---|---|
Hyperamylasemia after post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
Topics: Adolescent; Adult; Amylases; Bilirubin; Humans; Lipase; Lymph Node Excision; Male; Metabolic Disease | 1995 |
19 other studies available for 1-anilino-8-naphthalenesulfonate and Metabolic Diseases
| Article | Year |
|---|---|
Topics: Animals; Ascophyllum; Cholesterol; Diet; Fucus; Hyperlipidemias; Hypolipidemic Agents; Inflammation; | 2022 |
Iridoid- and flavonoid-enriched fractions of
Topics: alpha-Glucosidases; Anti-Inflammatory Agents; Antioxidants; Cornus; Flavonoids; Fruit; Galactosides; | 2023 |
Two Novel PNLIP Mutations Causing Congenital Lipase Deficiency in Identical Twin Boys.
Topics: Humans; Lipase; Male; Metabolic Diseases; Mutation; Pancreas; Twins, Monozygotic | 2020 |
Fluoxetine ameliorates high-fat diet-induced metabolic abnormalities partially via reduced adipose triglyceride lipase-mediated adipocyte lipolysis.
Topics: Adipocytes; Adipose Tissue; Adipose Tissue, White; Animals; Behavior, Animal; Depression; Diet, High | 2021 |
Leopoldia comosa prevents metabolic disorders in rats with high-fat diet-induced obesity.
Topics: Amylases; Animals; Anti-Obesity Agents; Asparagaceae; Diet, High-Fat; Disease Models, Animal; Lipase | 2019 |
Study of Family Clustering and PNPLA3 Gene Polymorphism in Pediatric Non Alcoholic Fatty Liver Disease.
Topics: Adolescent; Child; Cross-Sectional Studies; Female; Genetic Markers; Genetic Predisposition to Disea | 2018 |
Salacia reticulata has therapeutic effects on obesity.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adiponectin; Adipose Tissue; AMP-Activated Protein Kinases; | 2014 |
I148M variant in PNPLA3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease.
Topics: Adult; Body Mass Index; Genetic Predisposition to Disease; Humans; Insulin Resistance; Lipase; Liver | 2015 |
Immunoproteasome subunit LMP7 Deficiency Improves Obesity and Metabolic Disorders.
Topics: Adiponectin; Adipose Tissue; Animals; Antigens, CD; Bone Marrow Transplantation; Chemokines; Diet, H | 2015 |
Effect of metabolic disorders accompanying gastroenteritis on the pancreatic exocrine function in piglets. B. Disturbances of the pancreatic exocrine function in piglets with gastroenteritis.
Topics: Aging; Amylases; Animals; Case-Control Studies; Diarrhea; Feces; Female; Gastroenteritis; Lipase; Ma | 2002 |
[Research on lipases in the urogenital apparatus in man. I. Lipases in normal and pathological kidney].
Topics: Humans; Kidney; Kidney Diseases; Lipase; Male; Metabolic Diseases | 1956 |
[Research on lipases in the urogenital apparatus in man. I. Lipases in normal and pathological kidney].
Topics: Humans; Kidney; Kidney Diseases; Lipase; Male; Metabolic Diseases | 1956 |
[Research on lipases in the urogenital apparatus in man. I. Lipases in normal and pathological kidney].
Topics: Humans; Kidney; Kidney Diseases; Lipase; Male; Metabolic Diseases | 1956 |
[Research on lipases in the urogenital apparatus in man. I. Lipases in normal and pathological kidney].
Topics: Humans; Kidney; Kidney Diseases; Lipase; Male; Metabolic Diseases | 1956 |
[ACTIVITY OF ENDOGENOUS LIPOPROTEINS AND LIPASE IN THE BLOOD OF NORMAL SUBJECTS AND PATIENTS WITH ESSENTIAL HYPERLIPEMIA].
Topics: Arginine; Humans; Hyperlipidemias; Infant; Intellectual Disability; Lipase; Lipoproteins; Metabolic | 1965 |
[Are sports contraindicated in metabolic diseases?].
Topics: Arterial Occlusive Diseases; Blood Glucose; Coronary Disease; Diabetes Mellitus; Energy Metabolism; | 1982 |
[Drug clinics. How I treat various metabolic diseases treated by a drug intervention that targets the intestine].
Topics: Acarbose; Anion Exchange Resins; Anti-Obesity Agents; Cholestyramine Resin; Diabetes Mellitus; Enzym | 1998 |
Persistent hyperlipasemia caused by macrolipase in an adolescent.
Topics: Acute Disease; Adolescent; Diagnosis, Differential; Female; Humans; Immunoglobulin G; Immunologic Te | 2002 |
Molecular biology of metabolic disease: defects in the regulation of enzymic activity.
Topics: Adipose Tissue; Allosteric Regulation; Catalysis; Citrates; Enzyme Activation; Humans; Hydroxymethyl | 1978 |
[Metabolic disorders in alimentary adiposity and their dynamics under the effects of treatment].
Topics: Adipose Tissue; Adolescent; Adult; Aged; Humans; Lipase; Lipoprotein Lipase; Metabolic Diseases; Mid | 1974 |
[A case of transitory insufficiency of pancreatic lipase].
Topics: Child, Preschool; Female; Humans; Lipase; Metabolic Diseases; Pancreas | 1967 |
Medium-chain triglycerides.
Topics: Absorption; Fatty Acids, Nonesterified; Lipase; Metabolic Diseases; Triglycerides | 1968 |